drugset / Trial / NCT04114097

The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

NCT04114097

Phase 4 Completed 36 enrolled Jacob Thyssen LEO Pharma · collab
RandomizedParallel-groupQuadruple-blindOther

Summary

The investigators believe that the emerging epidemiological evidence connecting topical use of corticosteroids to the development of type 2 diabetes and osteoporosis point to potentially massive, yet clinically unacknowledged problems associated with topical corticosteroid treatment. Using state-of-the-art methodology, the present study will delineate the impact of topical corticosteroid use on insulin sensitivity and bone turnover markers in patients with atopic dermatitis and, thus, provide important data that may have implications for millions of people using topical corticosteroids.

Timeline

Start
2019-08-22
Primary completion
2021-03-15
Completion
2021-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule 0.1 % Topical
Subject betamethasone dipropionate Small molecule 0.1 % Topical

Indications